FDA Revamps Anti-Smoking, Vaping Initiative

February 27, 2020 by Alec Stone MA, MPA, Former ONS Director of Government Affairs and Advocacy
alec stone
Alec Stone MA, MPA, ONS Public Affairs Director

In late 2019, Congress passed a bill to raise the national age of purchase (https://voice.ons.org/advocacy/legislation-raises-minimum-age-of-sale-for-tobacco-products-to-21) for tobacco and vaping products from 18 to 21, and further efforts to curb smoking rates have been championed at all levels of government. In the past, the U.S. Food and Drug Administration (FDA) had been called out for its lack of action on youth vaping (https://voice.ons.org/advocacy/durbin-calls-out-fda-medicare-for-all-support-cancer-mortality-drops), but the agency is working to change that for the future.

FDA has revamped its Real Cost anti-smoking campaign (https://www.fda.gov/tobacco-products/public-health-education/real-cost-campaign#1) to focus on e-cigarette use among teenagers. According to reports, more than 2.1 million middle and high school students (https://www.fda.gov/tobacco-products/public-health-education/real-cost-campaign#1) used e-cigarettes and vaping mechanisms in 2017, leading to questions about the availability of vaping devices in schools across the country. In response, FDA targeted its e-cigarette and vaping campaign to focus on school-age children who have used or could potentially use e-cigarettes.

The initiative launched attention-grabbing advertisements, commercials, posters, and public service announcements directed at students aged 12–17 to highlight the dangers associated with vaping. The messages target the “cost-free” mentality that young smokers have about vaping, assuming it won’t have any ill effects on their health. After a flurry of lung-related illness associated with vaping in 2019 (https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html), the initiative illustrates the harm connected with the devices. Resources are available on FDA’s Real Cost website.

As champions of the public health, nurses are essential to the vaping conversation. ONS issued a revised position statement (https://www.ons.org/make-difference/ons-center-advocacy-and-health-policy/position-statements/e-cigarettes-and-vaping) on the use of e-cigarettes and vaping, focused efforts at the 2019 Capitol Hill Days to offer the nursing perspective to lawmakers and elected officials, and is holding a meeting on March 5, 2020 with student and pediatric nursing organizations to collaborate and share resources. When nurses speak, people listen, and they will be central to addressing the youth vaping epidemic (https://www.ons.org/podcasts/episode-55-youth-vaping-epidemic).


Copyright © 2020 by the Oncology Nursing Society. User has permission to print one copy for personal or unit-based educational use. Contact pubpermissions@ons.org for quantity reprints or permission to adapt, excerpt, post online, or reuse ONS Voice content for any other purpose.